HIGHLIGHTS
- who: Paulien G de Jong from the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef, AZ Amsterdam, the Netherlands have published the article: ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial, in the Journal: (JOURNAL) of 19/03/2012
- what: The aim of the ALIFE2 study is therefore to evaluate the efficacy of low-molecular-weight heparin (LMWH) in women with inherited and with live birth as the primary outcome. The authors aim to increase the number of recruiting . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.